Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) can reduce the risk of developing stomach cancer when used over a long period of time, a new study says.
Agence France-Presse reports that researchers from Hong Kong, reviewing data from 2 831stomach cancer patients, found that long-term use of aspirin or NSAIDs cut the risk of developing the disease by 22 percent.
Still a bit early
But one of the researchers told AFP that it was far too soon to say that aspirin could be used as a treatment for stomach cancer. "The results we have at this stage is for prevention only and we do not want to cause confusion that this could also be for treatment purposes," said the researcher, Benjamin Wong from the University of Hong Kong's Faculty of Medicine.
Common type of cancer
According to the AFP account, stomach cancer is the fourth most common cancer in the world, and the second leading cancer killer.
The research appears in the latest issue of the American Journal of the National Cancer Institute. – (HealthDayNews)